These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 33529369)

  • 1. Necrobiotic xanthogranuloma in IgG-κ multiple myeloma.
    Giacalone S; Genovese G; Benzecry V; Berti E; Cusini M
    Br J Haematol; 2021 Apr; 193(2):211. PubMed ID: 33529369
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
    Higgins LS; Go RS; Dingli D; Kumar SK; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lust JA; Kapoor P; Leung N; Lin Y; Kourelis TV; Gertz MA; Kyle RA; Gonsalves WI
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):447-52. PubMed ID: 27238425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrafacial necrobiotic xanthogranuloma and monoclonal gammopathy: two cases.
    Legrand A; Jullie ML; Ly S; Beylot-Barry M; Viallard JF; Calonje J; Bureau-Lenoir C; Doutre MS
    Int J Dermatol; 2019 Jun; 58(6):e112-e114. PubMed ID: 30883695
    [No Abstract]   [Full Text] [Related]  

  • 4. Solitary necrobiotic xanthogranuloma of an upper extremity in association with multiple myeloma.
    Bain EE; Meehan SA; Hale EK
    J Drugs Dermatol; 2014 May; 13(5):598-600. PubMed ID: 24809886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Necrobiotic Xanthogranuloma as the Presenting Manifestation of Smouldering Myeloma.
    Makkar N; Niyas VKM; Swain S; Sethi P; Nischal N; Agarwal S; Ramam M; Wig N
    J Assoc Physicians India; 2019 Mar; 67(3):87-88. PubMed ID: 31304718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of monoclonal gammopathy of cutaneous significance with multiple organs involvement: Comment on "Concurrent acquired cutis laxa and necrobiotic xanthogranuloma without paraproteinemia".
    Zhang L; Jin L; Zhao Y; Cai H; Gu W
    J Dermatol; 2024 Oct; 51(10):e367-e368. PubMed ID: 38629318
    [No Abstract]   [Full Text] [Related]  

  • 7. Necrobiotic xanthogranuloma associated with monoclonal gammopathy of unknown significance.
    Melguizo Moya I; Navarro Puerto MA; Grilo Reina A
    Med Clin (Barc); 2017 Dec; 149(11):509-510. PubMed ID: 28736067
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diffuse plane normolipemic xanthomatosis and necrobiotic xanthogranuloma associated with monoclonal gammopathy--determining the disease stage with PET-CT and treatment experience. Two case studies and literature review].
    Adam Z; Zahradová L; Krejcí M; Pour L; Koukalová R; Rehák Z; Feit J; Kren L; Mechl M; Vasků V; Sirotková A; Hájek R; Mayer J
    Vnitr Lek; 2010 Nov; 56(11):1158-68. PubMed ID: 21250495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Kyle RA; San-Miguel JF; Mateos MV; Rajkumar SV
    Hematol Oncol Clin North Am; 2014 Oct; 28(5):775-90. PubMed ID: 25212882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Necrobiotic Xanthogranuloma With Associated Monoclonal Gammopathy Presenting as an Eyelid Nodule.
    Punyamurthy NT; Tjahjono LA; Harris GJ; Wanat KA
    Ophthalmic Plast Reconstr Surg; 2023 Sep-Oct 01; 39(5):e148-e150. PubMed ID: 37279015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Complete remission of necrobiotic xanthogranuloma after disappearance of monoclonal immunoglobulin induced by bortezomib, lenalidomid and dexamethasone].
    Adam Z; Pour L; Řehák Z; Dvořáková K; Koukalová R; Feit J; Kameník P; Krejčí M; Štork M; Krejčí M; Sandecká V; Boichuk I; Král Z
    Vnitr Lek; 2021; 67(6):352-356. PubMed ID: 35459378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stupendous skin nodules: Necrobiotic xanthogranuloma with IgA-λ and IgG-κ monoclonal gammopathy.
    Liu Z; Cao X; Wan C
    J Dermatol; 2023 Feb; 50(2):e89-e91. PubMed ID: 36317505
    [No Abstract]   [Full Text] [Related]  

  • 13. Flaming cells in IgG myeloma.
    Miyoshi I; Saito T; Taguchi H
    Intern Med; 2004 Jul; 43(7):638. PubMed ID: 15335201
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral necrobiotic xanthogranuloma of the eyelids followed by a diagnosis of multiple myeloma 20 years later.
    Lam K; Brownstein S; Jordan DR; van der Jagt R; Jastrzebski A; Dionne MA
    Ophthalmic Plast Reconstr Surg; 2013; 29(5):e119-20. PubMed ID: 23247037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of CD81 for plasma cell dyscrasias.
    Binder M; Bacher U
    Leuk Res; 2014 Mar; 38(3):292-3. PubMed ID: 24462475
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracytoplasmic inclusions in plasma cells: A diagnostic adjunct in monoclonal gammopathy of undetermined significance.
    Gajendra S; Sharma R; Jain S; Sachdev R; Sood N
    Indian J Pathol Microbiol; 2017; 60(4):618-619. PubMed ID: 29323095
    [No Abstract]   [Full Text] [Related]  

  • 17. The predictive power of serum kappa/lambda ratios for discrimination between monoclonal gammopathy of undetermined significance and multiple myeloma.
    Bergón E; Miravalles E; Bergón E; Miranda I; Bergón M
    Clin Chem Lab Med; 2005; 43(1):32-7. PubMed ID: 15653439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma].
    Schleiffenbaum BE
    Praxis (Bern 1994); 2012 Nov; 101(24):1521-9; quiz 1530-1. PubMed ID: 23184544
    [No Abstract]   [Full Text] [Related]  

  • 19. Necrobiotic Xanthogranuloma.
    Dellatorre G; Miqueloto JK
    JAMA Dermatol; 2020 Jun; 156(6):696. PubMed ID: 32374351
    [No Abstract]   [Full Text] [Related]  

  • 20. Diagnosis and management of multiple myeloma and related disorders.
    Kyle RA
    Prog Hematol; 1986; 14():257-82. PubMed ID: 2418463
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.